Skip to content
LongevityGraded

Review

Superpower Health Review: Is the $349 Lab Membership Worth It?

Superpower's $349/yr membership ($299 the first year) runs 150+ lab tests over two draws. The useful core is small, the panel padded, treatment unpriced.

Researched & graded by · Lead Reviews Analyst
Last graded
On this page

Evidence graded in this piece

  • A1strong
  • B1mixed
  • C2thin
How we grade
B

Featured partner

Grade B

CoreAge Rx

Clinician-reviewed NAD+ and sermorelin with published starting prices and human support. Confirm the full cost and renewal terms before paying.

$93–$99/mo (starting rates)

We may earn a commission through this link, at no extra cost to you.

Check availability
Pricing
Varies by plan
Pharmacy
503A compounding pharmacy
Labs
Depends on treatment
Consult
Clinician review included
Support
Human support included

Grades come from each provider's published terms. How we're funded

B

Partner

Grade B

System Labs

A real NAD+ and sermorelin menu with prices on the page — but every figure printed is a first month, not a rate you hold.

$89 first mo (from $149)

We may earn a commission through this link, at no extra cost to you.

Visit System Labs

Every published figure is a first-month teaser against a struck-through standing rate — "$89 /first mo" from "$149", "$109 /first mo" from "$219" — so the large number is not what a second month costs. Compounded and not FDA-approved. Graded on the same rubric as every other provider on our scorecard.

The one-sentence version

Superpower is a well-marketed, well-priced direct-to-consumer (DTC) lab membership that does one thing genuinely well — it surfaces a big panel, including a handful of cheap, outcome-validated markers your annual physical usually skips — and one thing it cannot do at all: actually treat you. The product is real and the price is competitive, but the "150+ biomarkers + a longevity dashboard" framing oversells what a tube of blood buys. At heart it is still a testing membership — treatment is something you reach through it, not something the fee covers — the long marker list is padded with correlated and vanity numbers, and the bigger story around the company — the well-publicized 2025 lawsuit between Function Health and Superpower over a former employee and trade-secret claims — is a business dispute, not a signal of clinical quality either way. Whether $349 a year is worth it depends entirely on whether you will act on the few markers that matter. For where lab memberships sit in the field, start with our pillar on longevity medicine: what's proven vs hyped and our breakdown of what longevity biomarker panels actually test.

What Superpower actually is

Superpower is a venture-backed DTC lab-testing startup (it raised a widely reported ~$30M round) that sells an annual membership. Its own membership page prices it at $349 a year, with $50 off for new members — so $299 your first year — and notes that pricing may vary in New York and New Jersey1. For the fee you get 150+ biomarkers across two blood draws (a baseline and a retest, each at a Quest location, or at home for an extra cost), a dashboard with a biological-age readout, a written action plan after each test, and chat access to its AI assistant and a care team. The pitch is concierge-grade data at a consumer price — and on price-per-marker, that part is broadly true.

At a glance

What it isDTC lab membership; 150+ markers across a baseline and a retest
Price$349/yr; $299 your first year with the new-member $50 off
Genuinely useful coreApoB, Lp(a) once, hs-CRP, HbA1c (outcome-validated)
Padding~half basic labs; correlated long tail; IGF-1 vanity
Treats your results?Not in the fee — prescriptions are an unpriced add-on
Function lawsuit?Business/personnel dispute — not a clinical signal
A well-priced product behind a 'longevity dashboard' headline: the actionable core is small, cheap, and real; the '150+' is mostly framing.

What the fee does not cover is treatment. The same page lists "access" to prescriptions, peptides and supplements, but it publishes no price for any of them, and the peptide page is a waitlist. Superpower surfaces and tracks numbers; managing a therapy is a separate purchase you cannot price in advance. That testing-versus-treating split is the structural catch of the entire DTC lab band, and it is the single most important thing to understand before paying. We map the whole band in longevity clinics vs lab memberships.

The good: it surfaces the markers a basic checkup skips

The honest case for Superpower is the same as for any well-built lab membership: a standard annual physical often orders a basic lipid panel, a metabolic panel, and a CBC, then stops. A big DTC panel routinely includes several well-established markers that your checkup probably doesn't (the research behind each one is in our guide to longevity biomarker panels):

  • ApoB counts the number of particles that can lodge in an artery wall. When it disagrees with standard LDL cholesterol (common in metabolic syndrome), it is the better read on heart risk.
  • Lp(a) is a largely inherited, lifelong-stable particle that raises heart-attack and stroke risk. You measure it once; a high result reshapes how aggressively everything else gets managed.
  • hs-CRP, a marker of low-grade inflammation, adds to the heart-risk picture alongside cholesterol.
  • HbA1c is average blood sugar over about three months, and risk rises across the whole range — not only above the diabetes cutoff.

If Superpower's panel gets these four numbers in front of a motivated person — plus catches a treatable thyroid, ferritin, or vitamin D problem people misattribute to "aging" — it has earned a real slice of its fee. That is the legitimate core, and on cost-per-marker Superpower is one of the cheaper ways to get it.

The catch: padding, and a "longevity" dashboard that does not treat

Now the honest case against the framing. The "150+ biomarkers" headline does a lot of marketing work:

  • A large share is ordinary bloodwork — CBC, metabolic panel, standard lipids, thyroid, electrolytes — useful, but the same labs a primary-care order or a cheap requisition provides. Bundling them into a "150+" count makes the panel look more exotic than it is.
  • Much of the tail is correlated padding that tracks the cheap Tier-1 core, adding line items and a sense of completeness without much independent, actionable signal. More tubes of blood is not more health.
  • Some featured markers mislead as targets. IGF-1, marketed as a youth hormone, is not a number where higher is better — both low and high levels are linked to worse outcomes. And two of the strongest predictors of a long life aren't on any blood panel at all: cardiorespiratory fitness and grip strength (see VO2 max and longevity).

The decisive limit is structural: Superpower is a measurement product. It flags that your ApoB is high or your HbA1c is creeping up, and its plan suggests lifestyle, diet and supplement changes — but the fee does not buy someone to manage a treatment with you. A dashboard full of green-and-amber flags can create a false sense that paying for the data is doing something. For a health-literate person who will take an abnormal result to a clinician, that's fine; for someone hoping the membership itself improves their health, it's a category error.

Graded scorecard

  1. A
    Surfacing ApoB, Lp(a), hs-CRP, HbA1c cheaplyStrong evidence

    Well-established markers a basic checkup skips. ApoB beats LDL-C when they disagree; HbA1c risk rises across the whole range; Lp(a) is measured once.

  2. B
    The basic-labs half (CBC, metabolic, thyroid, ferritin, D)Moderate evidence

    Useful and treatable when abnormal — but ordinary bloodwork available more cheaply, not 'longevity' magic.

  3. C
    The '150+ biomarker longevity' framing as a health upgradeWeak evidence

    Much of the tail is correlated padding; IGF-1 is not a higher-is-better number. More tubes is not more health.

  4. D
    The membership itself as a health interventionInsufficient

    The fee buys testing, not treatment. Surfacing a flagged number is not moving an outcome; cardiorespiratory fitness and grip strength — the biggest survival levers — aren't even on the panel.

Two axes kept separate: the small actionable core plus competitive pricing (real) versus the 'longevity dashboard improves your health' promise (the fee buys testing, not treatment). Grades reflect the published evidence on each marker.

The Function Health lawsuit, in plain terms

Because it comes up in every "Superpower vs Function" search, it's worth stating cleanly: in 2025, Function Health sued Superpower in a dispute centered on a former Function employee and allegations involving confidential information / trade secrets. That is a business and personnel dispute between two competitors. It tells you the DTC-lab space is crowded and competitive; it does not tell you that either company's clinical product is better or worse. Don't let litigation headlines stand in for an evidence judgment about the panels themselves — for the rival product on the merits, see our Function Health review and the head-to-head Function Health vs Superpower.

The grade, and how we got there

Two axes, because conflating them is the trap:

  • As a cheap way to surface outcome-validated markers your checkup skips: moderate-to-strong. ApoB, Lp(a), hs-CRP, and HbA1c are real, hard-outcome-linked tests, and Superpower's price-per-marker is competitive.
  • As a "150+ biomarker longevity" upgrade that improves your health: weak. Roughly half is basic labs, much of the tail is correlated padding, a few markers (IGF-1) mislead as targets, and — decisively — the fee buys testing, not treatment.

That split lands the letter grade in the middle: a B for the actionable core and the price, a C for the "longevity dashboard" model most people think they're buying. If you're health-literate, have a clinician who'll act on the results, and value cheap convenient access to ApoB and Lp(a), it can be worth it. If you're hoping a subscription will make you healthier, the money does more in a targeted outcome-validated panel plus actually treating the few markers that matter. We run that whole cost-benefit in are longevity clinics worth it?.

Who should and shouldn't buy it

  • Reasonable buyer: a motivated, health-literate person who wants ApoB, Lp(a), hs-CRP, and HbA1c surfaced cheaply and will take abnormal results to a clinician who treats them.
  • Poor fit: someone expecting the membership to improve their health, or who'll read a long list of flags as a scoreboard. For most of that budget, a targeted panel plus treatment does the job — and if you mainly want a biological-age number, the open PhenoAge formula derives one from a basic blood draw for free, as we cover in free biological-age tests. Don't confuse a comprehensive blood panel with an epigenetic-age test — that's a different product with its own limits, graded in biological age tests.

Bottom line

Superpower's real value isn't the "150+ biomarkers" — it's the four or five cheap, outcome-validated markers (ApoB, Lp(a) once, hs-CRP, HbA1c) it surfaces at a competitive price, plus the occasional treatable deficiency catch. The rest is largely ordinary bloodwork dressed up by a big number, a correlated tail that adds little independent signal, and the occasional vanity marker. Most important, the $349 buys testing, not treatment: it flags problems the fee does not fix, and the Function Health lawsuit is a business story, not a clinical verdict. Worth it for a motivated buyer with a clinician who'll act on the results — a poor fit for anyone hoping a subscription is itself a health intervention. To see how it stacks up against InsideTracker, Lifeforce, and Function on price and padding, see our roundup of the best longevity blood test services. For a graded look at the labs and clinics selling these memberships, see our longevity clinic rankings.

Providers to compare

We may earn a commission through these links, at no extra cost to you. Disclosure

A

Partner

Luvo Health $199 per 4 weeks NAD+ or sermorelin

Visit Luvo Health

See every graded provider ↗

Frequently asked questions

Is Superpower Health worth $349 a year?

It depends on who you are. Superpower's own page prices the membership at $349 a year, $299 your first year with the new-member discount. For a motivated, health-literate person who wants outcome-validated markers like ApoB, Lp(a), hs-CRP and HbA1c surfaced cheaply — and who will take abnormal results to a clinician who treats them — Superpower's price-per-marker is competitive and it can be worth it. For someone hoping the subscription itself makes them healthier, it's a poorer fit: roughly half the panel is ordinary bloodwork, much of the rest is correlated padding, and the fee buys testing, not treatment.

What is the Function Health vs Superpower lawsuit about?

In 2025 Function Health sued Superpower in a dispute centered on a former Function employee and allegations involving confidential information and trade secrets. It is a business and personnel dispute between two competing DTC lab startups. It signals how crowded and competitive the space is — but it is not evidence that either company's panel is clinically better or worse, so it shouldn't drive your buying decision.

Does Superpower treat your results or just test them?

The membership fee covers testing, a written action plan and chat support, not treatment. Superpower's page lists access to prescriptions, peptides and supplements, but publishes no price for any of them, so you cannot tell in advance what treating a result through Superpower would cost. In practice, acting on an abnormal result often falls to you and your own clinician. That test-but-don't-treat structure is the defining limit of the DTC lab category and the main reason a subscription isn't itself a health intervention.

Are the '150+ biomarkers' actually useful?

A handful are genuinely useful — ApoB, Lp(a) once, hs-CRP and HbA1c are well-established and skipped by most basic checkups. But the headline number is mostly framing: a large share is ordinary bloodwork, much of the tail correlates with the cheap core and adds little independent signal, and markers like IGF-1 mislead as targets. Notably, two of the strongest longevity predictors — cardiorespiratory fitness and grip strength — aren't blood tests at all, so no panel captures them.

References

  1. Superpower (2026). Superpower — membership price, what the two blood draws test, and what the membership includes. Superpower website.

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.